Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

SAN DIEGO, CA / ACCESS Newswire / May 27, 2025 / Bora Biologics, a leading contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, announced a major ...

California's second-biggest city has loomed large over America's craft beer industry for decades. Thanks to a complex brew of local culture, regional access and market timing, San Diego came to define ...

Boundless Bio is in a bind. A phase 1/2 trial has revealed the shortcomings of Boundless’ lead candidate, prompting the ...

New owner is crafting a master plan for a mixed-use development with thousands of residential units, and ground-floor shops ...

As the United States cuts budgets and restricts immigration, China and Europe are offering researchers money and stability.

Trump’s “One Big Beautiful Bill Act,” if enshrined into law, could transform the current trade conflict into a capital war, ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

Story Feb. 4 - Turnstone Biologics: The San Diego biotech is seeking out “strategic alternatives” for its business and as it cuts work on its remaining pipeline program, the company is also ...

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long COVID ...

Hearing about artificial intelligence from inside Chinese business paints a very different picture of the tech than popularly ...